Detalhe da pesquisa
1.
Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease.
Blood
; 138(13): 1162-1171, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166491
2.
Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.
Blood
; 137(2): 269-280, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152749
3.
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
J Clin Microbiol
; 58(12)2020 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917729
4.
Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion.
J Clin Invest
; 133(18)2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490346
5.
Intermediate monocytes induced by IFN-γ inhibit cancer metastasis by promoting NK cell activation through FOXO1 and interleukin-27.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091454
6.
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
medRxiv
; 2020 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577675